Menten AI Using Nvidia's cuQuantum to Support Its Drug Discovery Work

Nvidia has disclosed that Menten AI is using its cuQuantum’s tensor network library to simulate protein interactions and optimize new drug molecules. Like many quantum early adopters, Menten AI is investigating the use of quantum technology to accelerate the computationally expensive simulations used in classical computing for protein and peptide design. But the challenge is that today's quantum processor are not really powerful enough to provide useful results. However, the processors are continuing to improve at a fast pace and it is likely they will become powerful enough to provide quantum advantage and provide solutions that cannot be achieved using classical computing. However, by using a high performance quantum simulator like the Nvidia GPU's and cuQuantum software library, they can develop quantum algorithms and test them before the larger machines are available. Menten AI may even be able to achieve early results in their protein simulation work using cuQuantum but will certainly be ready to scale up and use those same algorithms on the larger machines when they are available. Additional information can be found in an Nvidia blog available here which describes cuQuantum and Menten Ai's usage to help in drug discovery.

June 2, 2022